The cleaning agent specialist has launched the new VHP 100i and 1000i that are designed to be integrated into a facility's building automation and HVAC systems
STERIS has launched the next generation of integrated Vaporized Hydrogen Peroxide (VHP) biodecontamination systems for customers wanting to achieve up to a 6-log bioburden reduction in GMP pharmaceutical, medical device and research environments.
The new VHP 100i and 1000i are designed to be integrated into a facility's building automation and HVAC systems, and can run a decontamination cycle at programmed intervals or at the push of a button. This allows for easy and frequent decontamination of rooms, isolators, filling lines, RABs, pass-through chambers and more.
The systems allows for easy and frequent decontamination of rooms, isolators, filling lines, RABs, and pass through chambers
"The new VHP systems incorporate input received at thousands of VHP customer sites on five continents," said Andrea Conroy, VP of Marketing for Life Science Equipment and Service at STERIS. "They are engineered to streamline the user experience, offering greater configuration flexibility and ease-of-use."
STERIS VHP offers broad-spectrum decontamination to help increase productivity and efficiency and reduce this risk of error by replacing manual cleaning and disinfection steps. This is different from fogging systems because it is a dry, small-molecule process compatible with a broad range of surface materials - even sensitive electronic equipment.
The 100i and 1000i are both members of a family VHP products that leverage the technology's method of decontamination and sterilisation of spaces and products for critical applications and controlled environments across the life sciences industry.
Both systems also now include Vaprox Link for enhanced regulatory compliance.